Microvessel density and neovascularization of endometrium after uterine artery embolization with trisacryl gelatin microspheres

doi:10.3969/j.issn.2095-4344.2013.47.013

Abstract

Abstract:

BACKGROUND: Uterine arterial embolization is a minimally invasive technique and widely used for the treatment of several obstetrics and genecology diseases. However, reports about the influence of uterine arterial embolization on the pathophysiological microvessel density and angiogenesis changes in the endometrium have been very limited.
OBJECTIVE: To investigate the influence of uterine artery embolization on endometrial microvessel density and neovascularization.
METHODS: Sixty female guinea pigs were randomly divided into control group (n=15) and uterine artery embolization group (n=45). In the uterine artery embolization group, trisacryl gelatin microspheres (Embosphere) was used to perform uterine artery embolization and animals were further divided into three subgroups including E1, E2, and E3 (n=15 in each subgroup). Uterine specimens were collected at 7-15 days, 16-30 days, and 31-45 days after uterine artery embolization respectively in the three subgroups.

RESULTS AND CONCLUSION: Microspheres were visible in the lumen of primary branch of uterine artery, subserosal arteriole and intramuscular arteriole. Statistical analysis demonstrated that CD34-positive microvessel density of the endometrial basal layer significantly decreased after uterine artery embolization, and reverted to the normal level (P < 0.05). Increase of neovascularization with CD105-postive microvessel density presented after uterine artery embolization, and then returned to the normal (P < 0.05). These findings indicate that uterine artery embolization may lead to a temporal decrease of microvessel density in the endometrium which will recover over time as a result of the increase of CD105-postive neovascularization.

Key words: microspheres, endometrium, uterine artery embolization, microvessels, biocompatible materials

CLC Number:

R318

Tan Guo-sheng, Guo Wen-bo, Xiang Xian-hong, Zhang Bing, Chen Wei, Yang Jian-yong. Microvessel density and neovascularization of endometrium after uterine artery embolization with trisacryl gelatin microspheres[J]. Chinese Journal of Tissue Engineering Research, doi: 10.3969/j.issn.2095-4344.2013.47.013.

Figures/Tables 3

References

[1] Ravina JH, Herbreteau D, Ciraru-Vigneron N, et al. Arterial embolisation to treat uterine myomata. Lancet. 1995;346 (8976):671-672.
[2] Goodwin SC, Bradley LD, Lipman JC, et al. Uterine artery embolization versus myomectomy: a multicenter comparative study. Fertil Steril. 2006;85(1):14-21.
[3] Narayan A, Lee AS, Kuo GP, et al. Uterine artery embolization versus abdominal myomectomy: a long-term clinical outcome comparison. J Vasc Interv Radiol. 2010;21(7):1011-1017.
[4] Bratby MJ, Walker WJ. Uterine artery embolisation for symptomatic adenomyosis--mid-term results. Eur J Radiol. 2009;70(1):128-132.
[5] Kahn V, Pelage JP, Marret H. Uterine artery embolization for myomas treatment. Presse Med. 2013;42(7-8):1127-1132.
[6] Zhang B, Jiang ZB, Huang MS, et al. Uterine artery embolization combined with methotrexate in the treatment of cesarean scar pregnancy: results of a case series and review of the literature. J Vasc Interv Radiol. 2012;23(12):1582-1588.
[7] Mohan PP, Hamblin MH, Vogelzang RL. Uterine artery embolization and its effect on fertility. J Vasc Interv Radiol. 2013;24(7):925-930.
[8] Lessey BA. The role of the endometrium during embryo implantation. Hum Reprod. 2000;15 Suppl 6:39-50.
[9] Critchley HO, Saunders PT. Hormone receptor dynamics in a receptive human endometrium. Reprod Sci. 2009;16(2): 191-199.
[10] Chien LW, Au HK, Chen PL, et al. Assessment of uterine receptivity by the endometrial-subendometrial blood flow distribution pattern in women undergoing in vitro fertilization-embryo transfer. Fertil Steril. 2002;78(2):245-251.
[11] Lili? V, Tubi?-Pavlovi? A, Radovi?-Janosevi? D, et al. Assessment of endometrial receptivity by color Doppler and ultrasound imaging. Med Pregl. 2007;60(5-6):237-240.
[12] 中华人民共和国科学技术部. 关于善待实验动物的指导性意见. 2006-09-30.
[13] 谭国胜,杨建勇,郭文波,等. 应用三丙烯微球对豚鼠子宫肌瘤模型行子宫动脉栓塞的实验[J]. 中国组织工程研究与临床康复, 2010,14(8):1377-1381.
[14] 何秋明,肖尚杰,夏慧敏.大鼠阴道涂片的观察[J].广州医学院学报, 2007,35(4):54-56.
[15] Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol. 1995;147(1):9-19.
[16] 高英茂.组织学与胚胎学[M].北京:人民卫生出版社,2001: 296-298.
[17] Mercé LT, Barco MJ, Bau S, et al. Are endometrial parameters by three-dimensional ultrasound and power Doppler angiography related to in vitro fertilization/embryo transfer outcome? Fertil Steril. 2008;89(1):111-117.
[18] Matsuda Y, Hagio M, Ishiwata T. Nestin: a novel angiogenesis marker and possible target for tumor angiogenesis. World J Gastroenterol. 2013;19(1):42-48.
[19] da Silva BB, Lopes-Costa PV, dos Santos AR, et al. Comparison of three vascular endothelial markers in the evaluation of microvessel density in breast cancer. Eur J Gynaecol Oncol. 2009;30(3):285-288.
[20] Reiner CS, Roessle M, Thiesler T, et al. Computed tomography perfusion imaging of renal cell carcinoma: systematic comparison with histopathological angiogenic and prognostic markers. Invest Radiol. 2013;48(4):183-191.
[21] Kopczyńska E, Makarewicz R. Endoglin - a marker of vascular endothelial cell proliferation in cancer. Contemp Oncol (Pozn). 2012;16(1):68-71.
[22] Dallas NA, Samuel S, Xia L, et al. Endoglin (CD105): a marker of tumor vasculature and potential target for therapy. Clin Cancer Res. 2008;14(7):1931-1937.
[23] Ziebarth AJ, Nowsheen S, Steg AD, et al. Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer. Clin Cancer Res. 2013;19(1):170-182.
[24] Lee NY, Golzio C, Gatza CE, et al. Endoglin regulates PI3-kinase/Akt trafficking and signaling to alter endothelial capillary stability during angiogenesis. Mol Biol Cell. 2012; 23(13):2412-2423.
[25] 于建宪,常宏,纪萍.CD105、CD34及Ⅷ因子在不同生理状态下子宫内膜中的表达[J].齐鲁医学杂志,2005,20(3):189-194.
[26] Fan X, Heijnen CJ, van der Kooij MA, et al. The role and regulation of hypoxia-inducible factor-1alpha expression in brain development and neonatal hypoxic-ischemic brain injury. Brain Res Rev. 2009;62(1):99-108.
[27] Schipani E, Maes C, Carmeliet G, et al. Regulation of osteogenesis-angiogenesis coupling by HIFs and VEGF. J Bone Miner Res. 2009;24(8):1347-1353.
[28] Worthington-Kirsch RL, Siskin GP, Hegener P, et al. Comparison of the efficacy of the embolic agents acrylamido polyvinyl alcohol microspheres and tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas: a prospective randomized controlled trial. Cardiovasc Intervent Radiol. 2011;34(3):493-501.